Pacteon, a global provider of end-of-line packaging automation, is excited to announce the acquisition of ESS Technologies, Inc. (ESS or the Company). The addition of ESS brings state-of-the-art cartoning and packaging line integration capabilities into Pacteons portfolio and significantly strengthens its presence in the pharmaceutical and diagnostic markets.<\/p>\n
Founded in 1993, ESS provides complete packaging line design, equipment manufacturing, integration and automation solutions to the pharmaceutical, diagnostic, and cosmetic end markets. The Company has extensive experience designing, manufacturing and integrating cartoners, case packers, robotic palletizers and filling and capping equipment. With a focus and expertise in the pharmaceutical end market, the Company also offers packaging machinery with integrated serialization systems to meet stringent pharmaceutical track and trace mandates.<\/p>\n
ESS has a best-in-class offering and is a highly respected brand in the pharmaceutical, diagnostic and cosmetic end markets. We are excited about this partnership and for ESS to become part of the Pacteon family, said Pacteon CEO, Bob Brotzki.<\/p>\n
We are excited to be partnering with Pacteon for the next chapter of ESS growth story. Pacteon offers a unique set of resources and expertise that will help ESS continue to expand our presence in our core end markets, said ESS Technologies President & Founder, Kevin Browne.<\/p>\n
For more information on ESS Technologies, visit http:\/\/www.esstechnologies.com<\/a>.<\/p>\n <\/p>\n Read more: <\/p>\n Pacteon Acquires ESS Technologies, Provider of Automated Packaging Machinery Solutions to the Pharma & Diagnostic Markets - Healthcare Packaging<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Pacteon, a global provider of end-of-line packaging automation, is excited to announce the acquisition of ESS Technologies, Inc. (ESS or the Company). The addition of ESS brings state-of-the-art cartoning and packaging line integration capabilities into Pacteons portfolio and significantly strengthens its presence in the pharmaceutical and diagnostic markets Continue reading